Amster Rothstein and Ebenstein, LLP - Intellectual Property Law

Event Spotlight: NYIPLA PTAB Committee Tackles Arthrex Oral Argument at March 2 Meeting

March 2, 2021

The next monthly meeting of the NYIPLA PTAB Committee on March 2 at 4:00 p.m. ET, will discuss the oral argument from the day prior in Arthrex v. Smith & Nephew. (CLE credit will be offered).
 
Arthrex v. Smith & Nephew: As advocated by amicus curiae Askeladden LLC (represented by co-chair Charley Macedo and Member Chandler Sturm from Amster, Rothstein & Ebenstein LLP) and NYIPLA, the Supreme Court only accepted the threshold questions as to whether PTAB APJs were principal or inferior officers for purposes of the Appointment Clause of the U.S. Constitution, and if so, did the “fix” work.
 
We will begin our session with a presentation including a brief refresher of the Arthrex case prior to oral arguments and discuss what the parties argued during the oral argument held on March 1, 2021.
 
Member Chandler Sturm will be helping prepare this presentation.
 
We will then open up the discussion to the committee to share their thoughts and opinions on these important issues.
 
There is no charge to PTAB Committee members to attend, and CLE will be available.
 
Every month, the NYIPLA PTAB Committee holds video conference calls to discuss the latest and greatest events involving the PTAB. All members of the NYIPLA are welcome to join the PTAB Committee at no extra cost and participate in these discussions and presentations.
 
If you are already registered as a member, you should have the Zoom log-in information. If you are not, or do not have log-in information, please contact Co-Chair, ARE Law partner Charley Macedo or committee coordinator ARE Law associate Chris Lisiewski.



View all In the Press

Print

Upcoming Events

View all Events >

RSS FEED

Never miss another publication. Our RSS feed (what is RSS?) will inform you when new articles have been posted.

Amster Rothstein & Ebentein RSS Feed Subscribe now!

Linkedin AREnet Access
©2007-2021 Amster Rothstein & Ebenstein LLP.    All rights reserved. | Disclaimer